Cresco Labs (CRLBF) Share-based Compensation (2020 - 2026)
Cresco Labs (CRLBF) reported Share-based Compensation of $5.3 million for Q1 2026, up 92.99% on a YoY basis from $2.7 million in Q1 2025, and up 43.85% quarter-over-quarter from $3.7 million in Q4 2025.
Cresco Labs (CRLBF) Share-based Compensation (2020 - 2026) Analysis & Trends
Cresco Labs has reported Share-based Compensation for 7 years, with the latest figure at $5.3 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 92.99% year-over-year to $5.3 million; the trailing twelve-month figure through Mar 2026 stood at $13.8 million (up 8.47% YoY), and the FY2025 full-year result was $11.2 million, down 20.69% from the prior year.
- Share-based Compensation for Q1 2026 stood at $5.3 million, up from $3.7 million in the prior quarter.
- The five-year high for Share-based Compensation was $7.5 million in Q1 2022, with the low at $2.2 million in Q2 2023.
- Historically, Share-based Compensation has averaged $4.1 million across 5 years, with a median of $3.7 million in 2025.
- Annual changes were most pronounced in 2023 — Share-based Compensation slumped 70.4% — and 2026, when it soared 92.99%.
- Cresco Labs' Share-based Compensation stood at $5.3 million in 2022, then plunged by 42.76% to $3.0 million in 2023, then advanced by 22.8% to $3.7 million in 2024, then declined by 1.4% to $3.7 million in 2025, then soared by 43.85% to $5.3 million in 2026.
- The last three Share-based Compensation figures came in at $5.3 million (Q1 2026), $3.7 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 36.86 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn | 5.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.26 Mn |
| Mar 31, 2026 | 5.26 Mn |
| Dec 31, 2025 | 3.65 Mn |
| Dec 31, 2025 | 3.65 Mn |
| Sep 30, 2025 | 2.31 Mn |
| Sep 30, 2025 | 2.31 Mn |
| Jun 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 2.55 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Dec 31, 2023 | 3.02 Mn |
| Dec 31, 2023 | 3.02 Mn |